Skip to content

Alberta Hip and Knee Replacement Project

A Randomized Controlled Prospective Study to Examine the Effectiveness of a New Evidence Based Arthroplasty Care Model for Patients With Severe Degenerative Joint Disease (DJD) of the Hip or Knee in Alberta

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00277186
Enrollment
3434
Registered
2006-01-16
Start date
2005-04-30
Completion date
2006-05-31
Last updated
2008-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee

Keywords

Arthroplasty, Health services research, Intent to treat, Randomized, Controlled

Brief summary

The study aims to determine if a New Arthroplasty Care Model, established on evidence-based medicine and best practices, will improve patient outcomes and improve cost effectiveness for patients with severe degenerative joint disease of the hip or knee in Alberta

Detailed description

The Alberta Orthopaedic Society through its Arthroplasty Service Design Working Group has, after carefully reviewing the existing conventional approach to arthroplasty care, developed what they believe could be a much improved new evidence based arthroplasty care model. This model represents how ideally a patient would access and receive health services across the complete continuum of care. In addition, wherever possible, evidence gathered from the literature and from known best practices has been utilized to develop standards related to access, wait times, clinical quality, resource use and health outcome measures. Where no evidence or known best practices exist, a standard that best support achieving other known standards are being developed. This new evidence based arthroplasty model seeks to significantly minimize and where possible, eliminate all the current gaps and barriers to arthroplasty care. This study will seek to prove that the new evidence based arthroplasty model will deliver improved patient outcomes with improved cost effectiveness. Once proven, it is anticipated that this new evidence based arthroplasty model will become the standard of care in Alberta, and a model for other jurisdictions to use in their health service re-designs

Interventions

OTHERNew Care Continuum

Patient experience surgery through newly designed arthroplasty continuum

Sponsors

Alberta Medical Association
CollaboratorOTHER
Calgary Health Region
CollaboratorOTHER
David Thompson Health Region
CollaboratorUNKNOWN
Capital Health Region
CollaboratorUNKNOWN
Alberta Health & Wellness
CollaboratorOTHER_GOV
Alberta Bone and Joint Health Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is at least 18 years of age * Patient is able to provide written consent

Exclusion criteria

* Patient has previously undergone arthroplasty of the same hip or knee (revision) * Patient has a surgical date scheduled for arthroplasty * Patient requires a hip resurfacing procedure or an oxford knee * Patient has a concurrent medical condition that would contraindicate the patients' ability to participate fully in the study procedures, including terminal conditions such as chronic obstructive pulmonary disease, end stage renal disease, heart failure, malignancy with an anticipated life expectancy of ≤ 2 years * Patient has senile dementia or Alzheimer's disease

Design outcomes

Primary

MeasureTime frame
health related quality of life scores3 month and 12 months post-surgery

Secondary

MeasureTime frame
patient satisfaction3 month and 12 months post-surgery
provider satisfaction3 month and 12 months post-surgery
cost utility3 month and 12 months post-surgery
wait timePre-surgery
safety3 month and 12 months post-surgery
health resource utilization3 month and 12 months post-surgery

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026